Selected publications

  • VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system

  • RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics

  • Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis

  • YAP1 and PRDM14 converge to regulate cell survival and tumorigenesis

  • Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy

  • CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer